Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Phibro Animal HealthPAHC -3.41%75 Dividend Payout Ratio is 0.16 as of Mar. 2026, which is 52% below its 10-year median of 0.33. GuruFocus rates PAHC with a GF Score™ of 75/100 and a GF Value™ of $29.54 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 448 Drug Manufacturers companies, Phibro Animal Health ranks better than 81.47% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Phibro Animal Health's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.16.
The historical rank and industry rank for Phibro Animal Health's Dividend Payout Ratio or its related term are showing as below:
PAHC'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.16 Med: 0.33 Max: 0.44
Current: 0.16
During the past 13 years, the highest Dividend Payout Ratio of Phibro Animal Health was 0.44. The lowest was 0.16. And the median was 0.33.
PAHC's Dividend Payout Ratio is ranked better than 81.47% of 448
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs PAHC: 0.16
During the past 13 years, the highest Trailing Annual Dividend Yield of Phibro Animal Health was 4.97%. The lowest was 0.79%. And the median was 1.96%.
During the past 10 years, the average Dividends Per Share Growth Rate was 2.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Phibro Animal Health was 6.30% per year. The lowest was 0.00% per year. And the median was 0.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Phibro Animal Health (NAS:PAHC) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Phibro Animal Health Dividend Payout Ratio Related Terms
Phibro Animal Health Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Phibro Animal Health's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PAHC vs PRGO, HROW, XERS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phibro Animal Health Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Phibro Animal Health's Dividend Payout Ratio falls into.
Phibro Animal Health Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Phibro Animal Health's Dividend Payout Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health (PAHC) has a Dividend Payout Ratio of 0.16 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Phibro Animal Health and its competitors. This is 52% below median its historical median of 0.33. Over the past decade, Phibro Animal Health's Dividend Payout Ratio has ranged from 0.16 to 0.44. According to the industry distribution chart, Phibro Animal Health ranks #83 out of 448 companies in the Drug Manufacturers industry, placing it in the top 18.5%.
Is Phibro Animal Health's Dividend Payout Ratio too high?
Phibro Animal Health's current Dividend Payout Ratio of 0.16 is 52% below median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 0.44. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Phibro Animal Health's value of 0.16 is 57.3% below this industry median. Based on the distribution chart, Phibro Animal Health ranks #83 out of 448 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Phibro Animal Health has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Phibro Animal Health's Dividend Payout Ratio compare to PRGO and HROW?
According to the Drug Manufacturers industry distribution chart, Phibro Animal Health ranks #83 out of 448 companies for Dividend Payout Ratio. This places Phibro Animal Health in the top 19% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. Phibro Animal Health's value of 0.16 is 57.3% below this benchmark. Historically, Phibro Animal Health's own Dividend Payout Ratio has ranged from 0.16 to 0.44 over the past decade. While the company's 10-year median is 0.33 vs. the industry median of 0.38, Phibro Animal Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 448 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phibro Animal Health's current Dividend Payout Ratio of 0.16 is 57.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Phibro Animal Health and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phibro Animal Health's current Dividend Payout Ratio is 0.16, which is 52% below median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phibro Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Phibro Animal Health (PAHC) is currently considered Modestly Overvalued. The stock's GF Value™ is $29.54, compared to a current price of $34.26 — trading 16% above its estimated fair value. The current Dividend Payout Ratio is 0.16, which is 52% below median its 10-year median of 0.33 and 57.3% below the Drug Manufacturers industry median of 0.38. Phibro Animal Health's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Phibro Animal Health (PAHC), the current Dividend Payout Ratio is 0.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phibro Animal Health (PAHC) Overvalued in 2026?
Based on GuruFocus' analysis, Phibro Animal Health stock appears to be overvalued.
The current stock price of $34.26 is trading 16% above its estimated GF Value™ of $29.54.
GuruFocus considers Phibro Animal Health to be Modestly Overvalued.
Key valuation signals for PAHC:
Dividend Payout Ratio: 0.16 (52% below median its 10-year median of 0.33)
GF Value™: $29.54 vs. price of $34.26 (16% above fair value)
Industry Position: 57.3% below the Drug Manufacturers median (#83 of 448)
No single metric tells the full story. See the PAHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
75GF Score
Get the complete analysis for PAHC
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PAHC has been successfully added to your 
